| # | Drug | Count |
|---|---|---|
| 0 | LEVETIRACETAM | 86 |
| 1 | METHOTREXATE SODIUM | 76 |
| 2 | METHOTREXATE | 66 |
| 3 | LEVETIRACETAM IN SODIUM CHLORIDE | 64 |
| 4 | LEVETIRACETAM INJECTION | 64 |
| 5 | LEVETIRACETAM ORAL | 64 |
| 6 | CARBAMAZEPINE | 61 |
| 7 | LAMOTRIGINE | 60 |
| 8 | PREDNISONE | 46 |
| 9 | LAMOTIRIGINE | 41 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRADIOL AND NORETHINDRONE ACETATE | 1 | 0.0026 |
| 1 | PHENOBARBITAL SODIUM | 1 | 0.0024 |
| 2 | MERCAPTOPURINE | 34 | 0.0020 |
| 3 | BUTALBITAL AND ACETAMINOPHEN | 1 | 0.0016 |
| 4 | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE | 1 | 0.0015 |
| 5 | ZONISAMIDE | 12 | 0.0011 |
| 6 | OXCARBAZEPINE | 15 | 0.0010 |
| 7 | CLOBAZAM | 17 | 0.0010 |
| 8 | CARBAMAZEPINE | 61 | 0.0009 |
| 9 | VIGABATRIN | 13 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Mood Stabilizer [EPC] | 92 |
| 1 | Anti-epileptic Agent [EPC] | 77 |
| 2 | Corticosteroid [EPC] | 75 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 66 |
| 4 | Benzodiazepine [EPC] | 46 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 6 | Atypical Antipsychotic [EPC] | 18 |
| 7 | Aromatase Inhibitor [EPC] | 13 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 13 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mood Stabilizer [EPC] | 92 | 0.0004 |
| 1 | Anti-epileptic Agent [EPC] | 77 | 0.0003 |
| 2 | Typical Antipsychotic [EPC] | 8 | 0.0003 |
| 3 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 2 | 0.0003 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 2 | 0.0003 |
| 5 | Contrast Agent for Ultrasound Imaging [EPC] | 1 | 0.0002 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 66 | 0.0001 |
| 7 | Serotonin Reuptake Inhibitor [EPC] | 12 | 0.0001 |
| 8 | Macrolide Antimicrobial [EPC] | 7 | 0.0001 |
| 9 | Aromatase Inhibitor [EPC] | 13 | 0.0001 |